BDBM350520 1-(4-chlorophenyl)-3-(2,4-dioxo- 1,3-diazaspiro[4,5]decan-3-yl) urea::US10208071, Table 2.1::US10434112, Table 2.1::US10799518, Structure TABLE 2.1

SMILES Clc1ccc(NC(=O)NN2C(=O)NC3(CCCCC3)C2=O)cc1

InChI Key InChIKey=ZBXUTNJNUSUWHP-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 350520   

TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350520(1-(4-chlorophenyl)-3-(2,4-dioxo- 1,3-diazaspiro[4,...)
Affinity DataEC50:  4.90E+4nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350520(1-(4-chlorophenyl)-3-(2,4-dioxo- 1,3-diazaspiro[4,...)
Affinity DataEC50:  49nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM350520(1-(4-chlorophenyl)-3-(2,4-dioxo- 1,3-diazaspiro[4,...)
Affinity DataEC50:  49nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In DepthDetails US Patent